Who is suitable for ARTAS iXi robotic hair transplant?

Written by Dr. Sarat Anandh, MD DVL

Medical Council registered dermatologist · 12 October 2026

Robotic assistance does not make every type of hair loss suitable for surgery. Diagnosis, donor reserve, hair characteristics, health and long-term planning all matter.

The most useful question before an ARTAS iXi robotic hair transplant is not how many grafts can be moved in one day. It is whether transplantation is the right step for this diagnosis and whether the donor area can support a result that still looks sensible as hair loss changes over time.

Key takeaway: Good candidacy begins with diagnosis and donor conservation, not with choosing a machine.

Start with the cause of hair loss

Hair transplantation is most often considered for patterned androgenetic hair loss. It may also have a role in selected stable scars or other carefully assessed situations. It does not address every cause of shedding or thinning. Alopecia areata, active scarring alopecia, untreated scalp inflammation, nutritional problems and recent telogen effluvium need a different evaluation. Moving follicles before the diagnosis is stable can waste a limited donor supply.

A doctor should examine the scalp and hair shafts, review the timeline and family history, and decide whether dermoscopy or blood tests are useful. Medical treatment may be discussed to stabilise native hair before or alongside surgery when appropriate.

Is the donor area strong enough?

The back and sides of the scalp are not an unlimited bank. The clinician assesses density, miniaturisation, hair calibre, colour contrast, curl and the size of the planned recipient area. A person with extensive future loss and a weak donor zone may not have enough grafts for the coverage they expect. Conservative spacing during FUE matters because overharvesting can create a visibly thin, moth-eaten donor area.

ARTAS iXi uses image guidance to map and select follicular units within a physician-defined harvest zone. This may support consistent spacing and angle alignment, but the software cannot create new donor follicles or decide a lifetime strategy by itself.

Hair type and regulatory indication matter

The manufacturer and US FDA clearance describe ARTAS for assisting hair-follicle harvesting in men with androgenetic alopecia who have black or brown straight hair, with later clearance covering recipient-site creation and implantation. Regulatory indications can differ between countries and system versions. The treating clinic should confirm that the device, hair characteristics and proposed steps fit the locally applicable indication.

This is particularly important when a patient has tightly curled hair, very light or grey hair, diffuse thinning, a small donor zone or a diagnosis other than male pattern loss. A different FUE approach, medical treatment or no surgery may be the safer recommendation. Women with patterned thinning require careful donor assessment because miniaturisation can also involve areas normally used for harvesting.

Health and expectations are part of candidacy

Tell the doctor about diabetes, bleeding problems, smoking, allergies, previous keloids, medicines and supplements. Active infection or inflammation should be managed first. The team also needs to discuss local anaesthesia, aftercare, time away from strenuous activity and how you would respond if density is more modest than an online photograph suggests.

A suitable candidate understands that FUE leaves small scars, transplanted hairs often shed initially and visible growth takes months. Existing native hair can continue to thin, so future medication or another procedure may still be considered. Surgery should redistribute hair in a way that remains believable, not chase a youthful hairline that consumes too many grafts.

Questions to ask at consultation

Ask who performs each step, how donor capacity is estimated, how many grafts are reasonable, what happens to grafts between harvesting and placement, and which complications the clinic can manage. The International Society of Hair Restoration Surgery advises patients to be cautious about claims of scarless surgery or a machine performing the entire operation.

At The Derm Edit in Anna Nagar West Extension and Mogappair, ARTAS iXi suitability is assessed by Dr. Sarat Anandh, MD DVL, a Medical Council registered dermatologist. The decision follows scalp examination and long-term planning rather than a standard package. Message us on WhatsApp for details.